Author:
Li Yan, ,Zhang Pingshu,An Zhijie,Ma Ying,Wang Yamin,Wang Liye,Liu Yunqiu,Yuan Xiaodong,Li Keli,Yin Zundong,Wang Huaqing,
Publisher
Chinese Center for Disease Control and Prevention
Subject
Public Health, Environmental and Occupational Health,Infectious Diseases,Epidemiology
Reference18 articles.
1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J 2017;49(3):1700214. http://dx.doi.org/10.1183/13993003.00214-2017.
2. Wang C, Xu JY, Yang L, Xu YJ, Zhang XY, Bai CX, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 2018;391(10131):1706 − 17. http://dx.doi.org/10.1016/S0140-6736(18)30841-9.
3. Expert Group Opinion on Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in China (updated 2017). Int J Respir 2017;37(14):1041 − 57. http://dx.doi.org/10.3760/cma.j.issn.1673-436X.2017.14.001. (In Chinese).
4. Li Y, Zhang PS, An ZJ, Yue CY, Wang YM, Liu YQ, et al. Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations. Respirology 2022;27(10):844 − 53. http://dx.doi.org/10.1111/resp.14309.
5. WHO. Considerations for pneumococcal vaccination in older adults. Wkly Epidemiol Rec 2021;96(23):217−28. https://apps.who.int/iris/handle/10665/341722.